Association oftaugene polymorphism with Parkinson’s disease
✍ Scribed by M. Zappia; G. Annesi; G. Nicoletti; P. Serra; G. Arabia; P. Pugliese; D. Messina; M. Caracciolo; N. Romeo; F. Annesi; A.A Pasqua; P. Spadafora; D. Civitelli; N. Romeo; A. Epifanio; L. Morgante; A. Quattrone
- Publisher
- Springer Milan
- Year
- 2003
- Tongue
- English
- Weight
- 39 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins.
## Abstract We describe a 35‐year‐old woman who developed parkinsonism in association with Addison's disease. The parkinsonism disappeared following treatment for Addison's disease without the use of antiparkinsonian drugs. This association stands unique although the pathophysiology remains unclear
## Abstract Alpha‐synuclein gene (__SNCA__) mutations cause familial Parkinsonism but the role of __SNCA__ variability in idiopathic Parkinson's disease (PD) remains incompletely defined. We report a study of __SNCA__ genetic variation in 452 idiopathic PD cases and 245 controls. __SNCA__ copy numb